Article
Tom Caravela
The Increasing Complexity of TODAYS Interview Process
Summary
In this episode, Nabhan Islam joins Tom Caravela to discuss the evolving landscape of the job market and its impact on MSL interviews. Nabhan shares his career journey and highlights changes in interview rounds, emphasizing situational awareness and personality assessments. The conversation delves into the reasons behind these transformations and offers strategies for job seekers to succeed. Key topics include the importance of honesty, authenticity, and leveraging personal strengths. Nabhan also explores building resilience in a competitive market, the benefits of in-person networking, and professional coaching. The episode concludes with resource recommendations and a preview of future topics.
Nabhan Islam, MD, Medical Science Liaison with Sanofi Canada shares his recent interview experience and the modern complexities that exist versus prior years.
Learn more about…
👉 What the interview process looks like now versus prior years
👉 What drastic changes have been made in hiring
👉 The challenges and pitfalls to be aware of when interviewing
👉 How to better prepare for the modern-day interview
👉 Advice for job seekers to find career success
MSL interviews, job market evolution, interview strategies, career success tips, professional networking
Related Topics
You May Also Like
Tom Caravela
Podcast
MSL Talk: Tom Caravela, Kurt Grady
The Inside OUT Interview
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
13 Common Interview Mistakes Keeping You From Your Next Job
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS